DD268946A5 - Verfahren zur herstellung des (5r,6s)-2-aminopethyl-6-[(1r)-1-hydroxyaethyl]-2-penem-3-carbonsaeure-minophyrats - Google Patents

Verfahren zur herstellung des (5r,6s)-2-aminopethyl-6-[(1r)-1-hydroxyaethyl]-2-penem-3-carbonsaeure-minophyrats Download PDF

Info

Publication number
DD268946A5
DD268946A5 DD87302154A DD30215487A DD268946A5 DD 268946 A5 DD268946 A5 DD 268946A5 DD 87302154 A DD87302154 A DD 87302154A DD 30215487 A DD30215487 A DD 30215487A DD 268946 A5 DD268946 A5 DD 268946A5
Authority
DD
German Democratic Republic
Prior art keywords
penem
water
aminomethyl
alkanol
carboxylic acid
Prior art date
Application number
DD87302154A
Other languages
German (de)
English (en)
Inventor
Hans Hirt
Hansjoerg Fugster
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD268946A5 publication Critical patent/DD268946A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD87302154A 1986-04-29 1987-04-27 Verfahren zur herstellung des (5r,6s)-2-aminopethyl-6-[(1r)-1-hydroxyaethyl]-2-penem-3-carbonsaeure-minophyrats DD268946A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH174786 1986-04-29

Publications (1)

Publication Number Publication Date
DD268946A5 true DD268946A5 (de) 1989-06-14

Family

ID=4217628

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87302154A DD268946A5 (de) 1986-04-29 1987-04-27 Verfahren zur herstellung des (5r,6s)-2-aminopethyl-6-[(1r)-1-hydroxyaethyl]-2-penem-3-carbonsaeure-minophyrats

Country Status (13)

Country Link
EP (1) EP0243921A3 (hu)
JP (1) JPS62258384A (hu)
KR (1) KR870010059A (hu)
AU (1) AU7212687A (hu)
DD (1) DD268946A5 (hu)
DK (1) DK216187A (hu)
FI (1) FI871835A (hu)
HU (1) HU196808B (hu)
IL (1) IL82338A0 (hu)
NO (1) NO871763L (hu)
NZ (1) NZ220122A (hu)
PT (1) PT84767B (hu)
ZA (1) ZA873010B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8818789D0 (en) * 1988-08-08 1988-09-07 Erba Carlo Spa Crystalline(5r 6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penem-carboxylic acid & pharmaceutical formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789551A (fr) * 1971-10-01 1973-03-29 Unilever Emery Nouveaux composes organometalliques
JPS49134819A (hu) * 1973-05-08 1974-12-25
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound

Also Published As

Publication number Publication date
PT84767B (en) 1989-06-09
HU196808B (en) 1989-01-30
HUT43852A (en) 1987-12-28
KR870010059A (ko) 1987-11-30
DK216187A (da) 1987-10-30
DK216187D0 (da) 1987-04-28
FI871835A0 (fi) 1987-04-27
EP0243921A3 (de) 1987-12-16
ZA873010B (en) 1987-12-30
IL82338A0 (en) 1987-10-30
JPS62258384A (ja) 1987-11-10
FI871835A (fi) 1987-10-30
PT84767A (en) 1987-05-01
NO871763L (no) 1987-10-30
NO871763D0 (no) 1987-04-28
AU7212687A (en) 1987-11-05
NZ220122A (en) 1989-01-06
EP0243921A2 (de) 1987-11-04

Similar Documents

Publication Publication Date Title
DE69429774T2 (de) Magnesium-omeprazol
DE69318077T2 (de) Triazolylthiomethylthiocephalosporin-Hydrochlorid, sein kristallines Hydrat und seine Herstellung
DE69719755T2 (de) Polymorphe verbindungen
DE69429708T2 (de) Galanthamin Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
DE69427332T2 (de) Galanthamin-Derivat, ein Verfahren zu seiner Herstellung und seine Verwendung als Medikament
EP0780390A1 (de) Kristallmodifikation des CDCH, Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE112012004944T5 (de) Kristalline Formen von Cabazitaxel und deren Herstellungsverfahren
DE69229339T2 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
DE69429570T2 (de) Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
DE60215213T2 (de) Herstellung von levofloxacin hemihydrat
DE69510999T2 (de) Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung
DE2614669C2 (de) Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung
DE60131416T2 (de) Chirale fluochinolon-argininsalzformen
DD273634A5 (de) Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins
DE602004010410T2 (de) Polymorphe form von 3-phenylsulfonyl-8-piperazin-1-yl-chinolin
DE68918107T2 (de) Rifapentin-hydrohalide.
EP1737859B1 (de) Neue kristalline form von 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo¬4.3.0 nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE69917282T2 (de) Verfahren zur herstellung von zofenopril-calciumsalz
DE60017399T2 (de) Diphosphat-salz von einem 4"-substitutierte-9-deoxo-9a-aza-9a-homoerythromyin-derivat und seine pharmazeutische zubereitung
DE69107098T2 (de) 2'-Deoxy-2'-Methylidenecytidin-dihydrat, Verfahren zu ihrer Herstellung und Mischmaterial.
DE2116066C3 (de) 7-Desoxy-7(S)-methoxy-lincomycin, dessen Säureadditionssalze und Verfahren zu deren Herstellung
DE3789264T2 (de) Beta-lactam-antibiotika.
DE69614936T2 (de) d4T polymorphe Form I Verfahren
DD268946A5 (de) Verfahren zur herstellung des (5r,6s)-2-aminopethyl-6-[(1r)-1-hydroxyaethyl]-2-penem-3-carbonsaeure-minophyrats
DE69418953T2 (de) Kristalle einer antimikrobiellen Verbindung